You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry

Citation Tools

Article menu

Download PDFPDF

XML
Neurology
Original research
Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Braune S, Rossnagel F, Dikow H, et al
Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry
BMJ Open 2021;11:e042480. doi: 10.1136/bmjopen-2020-042480